330 related articles for article (PubMed ID: 32761972)
21. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
Zhou MY; Cheng ML; Huang T; Hu RH; Zou GL; Li H; Zhang BF; Zhu JJ; Liu YM; Liu Y; Zhao XK
World J Gastroenterol; 2021 Oct; 27(40):6908-6926. PubMed ID: 34790014
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents.
Kennedy LL; Hargrove LA; Graf AB; Francis TC; Hodges KM; Nguyen QP; Ueno Y; Greene JF; Meng F; Huynh VD; Francis HL
Lab Invest; 2014 Dec; 94(12):1406-18. PubMed ID: 25365204
[TBL] [Abstract][Full Text] [Related]
23. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
24. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
25. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
[TBL] [Abstract][Full Text] [Related]
26. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
27. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
[TBL] [Abstract][Full Text] [Related]
28. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
29. Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro.
Tao YY; Wang QL; Shen L; Fu WW; Liu CH
Exp Biol Med (Maywood); 2013 Nov; 238(11):1284-96. PubMed ID: 24006304
[TBL] [Abstract][Full Text] [Related]
30. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
31. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
[TBL] [Abstract][Full Text] [Related]
32. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
33. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
Lu J; Zhang J; Wang Y; Sun Q
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
[TBL] [Abstract][Full Text] [Related]
34. Myocyte Enhancer Factor 2A Contributes to the TGF-β1-Mediated Cholangiocyte Epithelial to Mesenchymal Transition and Senescence in Cholestatic Liver Fibrosis.
Zhou G; Hou F; He H; Xue Y; Wang Y; Chen X; Zhu F
Front Biosci (Landmark Ed); 2022 Dec; 27(12):324. PubMed ID: 36624941
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
37. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
38. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
Zhou LH; Chen X
Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
[TBL] [Abstract][Full Text] [Related]
39. Dynamic expression of desmin, α-SMA and TGF-β1 during hepatic fibrogenesis induced by selective bile duct ligation in young rats.
Gonçalves JO; Tannuri AC; Coelho MC; Bendit I; Tannuri U
Braz J Med Biol Res; 2014 Oct; 47(10):850-7. PubMed ID: 25140817
[TBL] [Abstract][Full Text] [Related]
40. PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway.
Xu A; Li Y; Zhao W; Hou F; Li X; Sun L; Chen W; Yang A; Wu S; Zhang B; Yao J; Wang H; Huang J
J Mol Med (Berl); 2018 Feb; 96(2):119-133. PubMed ID: 29098317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
